243 related articles for article (PubMed ID: 8912878)
1. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethality.
Smith SR; Terminelli C; Denhardt G; Narula S; Thorbecke GJ
Cell Immunol; 1996 Nov; 173(2):207-14. PubMed ID: 8912878
[TBL] [Abstract][Full Text] [Related]
2. The cooperative effects of TNF-alpha and IFN-gamma are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia.
Smith SR; Terminelli C; Kenworthy-Bott L; Calzetta A; Donkin J
J Leukoc Biol; 1994 Jun; 55(6):711-8. PubMed ID: 8195696
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia.
Marchant A; Bruyns C; Vandenabeele P; Ducarme M; Gérard C; Delvaux A; De Groote D; Abramowicz D; Velu T; Goldman M
Eur J Immunol; 1994 May; 24(5):1167-71. PubMed ID: 8181527
[TBL] [Abstract][Full Text] [Related]
4. IFN-gamma is a master regulator of endotoxin shock syndrome in mice primed with heat-killed Propionibacterium acnes.
Kawa K; Tsutsui H; Uchiyama R; Kato J; Matsui K; Iwakura Y; Matsumoto T; Nakanishi K
Int Immunol; 2010 Mar; 22(3):157-66. PubMed ID: 20130231
[TBL] [Abstract][Full Text] [Related]
5. IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice.
Tsutsui H; Matsui K; Kawada N; Hyodo Y; Hayashi N; Okamura H; Higashino K; Nakanishi K
J Immunol; 1997 Oct; 159(8):3961-7. PubMed ID: 9378984
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12.
Shnyra A; Brewington R; Alipio A; Amura C; Morrison DC
J Immunol; 1998 Apr; 160(8):3729-36. PubMed ID: 9558074
[TBL] [Abstract][Full Text] [Related]
7. Dibutyryl cyclic AMP protects Corynebacterium parvum-treated mice against lipopolysaccharide-induced lethal toxicity.
Inoue H; Takahashi S; Nomoto K; Yoshikai Y
Cell Immunol; 1995 Apr; 162(1):1-7. PubMed ID: 7704897
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.
Wysocka M; Kubin M; Vieira LQ; Ozmen L; Garotta G; Scott P; Trinchieri G
Eur J Immunol; 1995 Mar; 25(3):672-6. PubMed ID: 7705395
[TBL] [Abstract][Full Text] [Related]
9. Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium acnes-primed IFN-gamma-deficient mice by a concomitant reduction of TNF-alpha, IL-12, and IL-18 production.
Tsuji H; Mukaida N; Harada A; Kaneko S; Matsushita E; Nakanuma Y; Tsutsui H; Okamura H; Nakanishi K; Tagawa Y; Iwakura Y; Kobayashi K; Matsushima K
J Immunol; 1999 Jan; 162(2):1049-55. PubMed ID: 9916732
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of NO in both unchallenged and LPS-challenged C. parvum-primed mice are attributable to the activity of a cytokine-inducible isoform of iNOS.
Smith SR; Manfra D; Davies L; Terminelli C; Denhardt G; Donkin J
J Leukoc Biol; 1997 Jan; 61(1):24-32. PubMed ID: 9000533
[TBL] [Abstract][Full Text] [Related]
11. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.
Doherty GM; Lange JR; Langstein HN; Alexander HR; Buresh CM; Norton JA
J Immunol; 1992 Sep; 149(5):1666-70. PubMed ID: 1506688
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum.
Smith SR; Calzetta A; Bankowski J; Kenworthy-Bott L; Terminelli C
J Leukoc Biol; 1993 Jul; 54(1):23-9. PubMed ID: 8336076
[TBL] [Abstract][Full Text] [Related]
13. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production.
Muchamuel T; Menon S; Pisacane P; Howard MC; Cockayne DA
J Immunol; 1997 Mar; 158(6):2898-903. PubMed ID: 9058827
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-13 effects on activated monocytes lead to novel cytokine secretion profiles intermediate between those induced by interleukin-10 and by interferon-gamma.
Minty A; Ferrara P; Caput D
Eur Cytokine Netw; 1997 Jun; 8(2):189-201. PubMed ID: 9262968
[TBL] [Abstract][Full Text] [Related]
15. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin.
Satoh M; Inagawa H; Shimada Y; Soma G; Oshima H; Mizuno D
J Biol Response Mod; 1987 Oct; 6(5):512-24. PubMed ID: 2445926
[TBL] [Abstract][Full Text] [Related]
16. Treatment with Y-40138, a multiple cytokine production modulator, inhibits lipopolysaccharide- or tumour necrosis factor-alpha-induced production of pro-inflammatory cytokines and augments interleukin-10.
Fukuda T; Hisadome M; Komatsu H
J Pharm Pharmacol; 2005 Nov; 57(11):1461-6. PubMed ID: 16259779
[TBL] [Abstract][Full Text] [Related]
17. The role of endogenous IFN-gamma, TNF-alpha and IL-10 in LPS-induced nitric oxide release in a mouse model.
ter Steege JC; van de Ven MW; Forget PP; Brouckaert P; Buurman WA
Cytokine; 1998 Feb; 10(2):115-23. PubMed ID: 9512901
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory cytokine production in interferon-gamma-primed mice, challenged with lipopolysaccharide. Inhibition by SK&F 86002 and interleukin-1 beta-converting enzyme inhibitor.
Spinelle-Jaegle S; Devillier P; Doucet S; Millet S; Banissi C; Diu-Hercend A; Ruuth E
Eur Cytokine Netw; 2001; 12(2):280-9. PubMed ID: 11399517
[TBL] [Abstract][Full Text] [Related]
19. Endogenous mouse interleukin-10 is up-regulated by exogenously administered recombinant human interleukin-10, but does not contribute to the efficacy of the human protein in mouse models of endotoxemia.
Smith SR; Terminelli C; Denhardt G; Manfra D; Davies L; Narula S
Immunopharmacology; 1999 Feb; 41(2):119-30. PubMed ID: 10102793
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G
J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
